Skip to main content

Table 2 Overall breast cancer risk in relation to selected SNPs

From: Genetic predisposition, parity, age at first childbirth and risk for breast cancer

SNP Rs number (Gene)

Case/control N

Breast cancer risk Crude OR (CI 95%)

Breast cancer risk Adjusted OR* (CI 95%)

Breast cancer risk Adjusted OR** (CI 95%)

rs2981582 (FGFR2)

    

CC

233/561

1.00

1.00

1.00

CT

356/653

1.31 (1.08-1.60)

1.31 (1.07-1.60)

1.31 (1.07-1.61)

TT

124/185

1.61 (1.23-2.12)

1.62 (1.23-2.13)

1.63 (1.23-2.16)

Per allele

 

1.28 (1.12-1.46)

1.28 (1.12-1.46)

1.28 (1.12-1.47)

rs1045485 (CASP8)

    

CC

185/374

1.00

1.00

1.00

CG

42/86

0.99 (0.66-1.49)

0.98 (0.65-1.48)

1.04 (0.69-1.58)

GG

8/10

1.62 (0.63-4.17)

1.61 (0.63-4.16)

1.73 (0.66-4.54)

Per allele

 

1.10 (0.79-1.51)

1.10 (0.80-1.54)

1.10 (0.79-1.54)

rs3803662 (TNRC9)

    

CC

353/780

1.00

1.00

1.00

CT

278/512

1.20 (0.99-1.46)

1.20 (0.99-1.46)

1.19 (0.98-1.45)

TT

64/95

1.49 (1.06-2.09)

1.49 (1.06-2.10)

1.47 (1.04-2.08)

Per allele

 

1.21 (1.05-1.40)

1.21 (1.05-1.40)

1.20 (1.04-1.39)

rs8051542 (TNRC9)

    

CC

192/443

1.00

1.00

1.00

CT

338/637

1.22 (0.99-1.52)

1.23 (0.99-1.52)

1.20 (0.97-1.50)

TT

149/272

1.26 (0.97-1.64)

1.27 (0.97-1.64)

1.24 (0.95-1.62)

Per allele

 

1.13 (1.00-1.29)

1.13 (1.00-1.29)

1.12 (0.99-1.28)

rs12443621 (TNRC9)

    

AA

195/451

1.00

1.00

1.00

AG

338/657

1.19 (0.96-1.47)

1.19 (0.96-1.47)

1.20 (0.97-1.49)

GG

165/275

1.39 (1.07-1.79)

1.39 (1.08-1.79)

1.42 (1.09-1.84)

Per allele

 

1.18 (1.04-1.34)

1.18 (1.04-1.34)

1.19 (1.04-1.35)

rs889312 (MAP3K1)

    

AA

322/737

1.00

1.00

1.00

AC

301/530

1.30 (1.07-1.58)

1.30 (1.07-1.58)

1.26 (1.03-1.53)

CC

66/118

1.28 (0.92-1.78)

1.28 (0.92-1.78)

1.29 (0.92-1.80)

Per allele

 

1.19 (1.04-1.37)

1.19 (1.04-1.37)

1.18 (1.02-1.36)

rs3817198 (LSP1)

    

TT

311/668

1.00

1.00

1.00

CT

282/555

1.09 (0.90-1.33)

1.09 (0.90-1.33)

1.06 (0.87-1.30)

CC

76/107

1.53 (1.10-2.11)

1.53 (1.11-2.11)

1.50 (1.08-2.09)

Per allele

 

1.18 (1.02-1.36)

1.18 (1.02-1.36)

1.17 (1.10-1.35)

rs2107425 (H19)

    

CC

361/637

1.00

1.00

1.00

CT

250/573

0.77 (0.63-0.94)

0.77 (0.63-0.94)

0.78 (0.64-0.95)

TT

68/145

0.83 (0.60-1.14)

0.83 (0.60-1.14)

0.83 (0.60-1.14)

Per allele

 

0.86 (0.74-0.99)

0.86 (0.74-0.99)

0.86 (0.75-0.99)

rs13281615 (8q24)

    

AA

245/533

1.00

1.00

1.00

AG

332/633

1.14 (0.93-1.40)

1.14 (0.93-1.40)

1.14 (0.93-1.40)

GG

117/204

1.25 (0.95-1.64)

1.25 (0.95-1.64)

1.25 (0.95-1.64)

Per allele

 

1.12 (0.98-1.28)

1.12 (0.98-1.28)

1.15 (1.00-1.31)

rs981782 (5p12)

    

TT

182/335

1.00

1.00

1.00

TG

352/685

0.95 (0.76-1.18)

0.95 (0.76-1.18)

0.91 (0.72-1.14)

GG

125/296

0.78 (0.59-1.03)

0.78 (0.59-1.03)

0.74 (0.56-0.98)

Per allele

 

0.89 (0.77-1.02)

0.89 (0.77-1.02)

0.87 (0.75-1.00)

rs30099 (5q)

    

CC

584/1139

1.00

1.00

1.00

CT

113/248

0.89 (0.70-1.13)

0.89 (0.70-1.14)

0.90 (0.71-1.16)

TT

11/12

1.79 (0.78-4.08)

1.79 (0.78-4.10)

1.79 (0.77-4.18)

Per allele

 

0.98 (0.79-1.21)

0.98 (0.79-1.22)

0.99 (0.80-1.24)

rs4666451 (2p)

    

GG

272/554

1.00

1.00

1.00

GA

299/574

1.06 (0.87-1.30)

1.06 (0.87-1.30)

1.08 (0.88-1.32)

AA

105/204

1.05 (0.80-1.38)

1.05 (0.79-1.38)

1.06 (0.80-1.40)

Per allele

 

1.03 (0.91-1.18)

1.03 (0.91-1.18)

1.04 (0.91-1.19)

rs13387042 (2q35)

    

AA

192/335

1.00

1.00

1.00

AG

330/657

1.08 (0.86-1.36)

1.08 (0.86-1.35)

1.08 (0.86-1.37)

GG

163/350

1.23 (0.95-1.59)

1.23 (0.95-1.59)

1.24 (0.96-1.62)

Per allele

 

0.90 (0.79-1.03)

0.90 (0.79-1.03)

0.90 (0.79-1.02)

rs7766585 (ESR1)

    

CC

518/1031

1.00

1.00

1.00

CT

172/348

0.98 (0.80-1.22)

0.98 (0.80-1.22)

0.98 (0.79-1.21)

TT

17/26

1.30 (0.70-2.42)

1.30 (0.70-2.42)

1.42 (0.76-2.67)

Per allele

 

1.03 (0.86-1.23)

1.03 (0.86-1.23)

1.03 (0.86-1.24)

  1. * Adjusted for matching variables (age and year of inclusion in study).
  2. ** Adjusted for matching variables (age and year of inclusion in study), and for selected confounders (socioeconomic status and exposure to HRT).